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Abstract 
Swainsonine (1, 2, 8-trihyroxyindolizidine, SW), a natural alkaloid, has been reported to ex-
hibit anti-cancer activity on several mouse models of human cancer and human cancers in vivo. 
However, the mechanisms of SW-mediated tumor regression are not clear. In this study, we 
investigated the effects of SW on several human lung cancer cell lines in vitro. The results 
showed that SW significantly inhibited these cells growth through induction of apoptosis in 
different  extent  in  vitro.  Further  studies  showed  that  SW  treatment  up-regulated  Bax, 
down-regulated Bcl-2 expression, promoted Bax translocation to mitochondria, activated 
mitochondria-mediated apoptotic pathway, which in turn caused the release of cytochrome c, 
the activation of caspase-9 and caspase-3, and the cleavage of poly (ADP-ribose) polymerase 
(PARP), resulting in A549 cell apoptosis. However, the expression of Fas, Fas ligand (FasL) or 
caspase-8 activity did not appear significant changes in the process of SW-induced apoptosis. 
Moreover, SW treatment inhibited Bcl-2 expression, promoted Bax translocation, cyto-
chrome c release and caspase-3 activity in xenograft tumor cells, resulting in a significant 
decrease of tumor volume and tumor weight in the SW-treated xenograft mice groups in 
comparison to the control group. Taken together, this study demonstrated for the first time 
that  SW  inhibited  A549  cancer  cells  growth  through  a  mitochondria-mediated,  caspa-
se-dependent apoptotic pathway in vitro and in vivo. 
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Introduction 
Swainsonine (1, 2, 8-trihyroxyindolizidine, SW), 
a natural plant alkaloid, was first isolated from the 
Australian legume Swainsona canescens and then iden-
tified  in  many Astragalus and Oxytropis species  (Le-
guminosae) [1, 2]. These plants are commonly called 
locoweeds,  found  in  China,  the  United  States,  and 
some other parts of the world [2, 3]. In China, there 
are at least 10 species of locoweeds widely growing in 
the  western  rangelands  covering  up  to  11  million 
hectares [4, 5], which will provide plentiful resources 
for SW study and application in different field. 
SW has attracted great interest for its anti-tumor 
property.  SW  not  only  suppresses  the  growth  and 
metastasis  of  murine  B16F10  melanoma  and 
MDAY-D2 lymphoid tumor cells in syngeneic mice, 
but also reduces the growth rate of human melanoma, 
colon and gastric carcinoma cells, as well as C6 glioma 
cells in vitro and in vivo [6-11]. Clinical trials with SW, 
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as an anti-tumor drug, have shown obviously curative 
effects  with  well  tolerance  in  the  patients  with  ad-
vanced malignancies [12, 13]. SW has also been shown 
to promote anti-tumor immunomodulatory activities 
of immune system and protect both murine and hu-
man bone marrow against the toxicity of chemother-
apeutic drugs [14-16]. Additionally, the enhancement 
effects of SW for the performance of anti-tumor agents 
such as 5-Fu and cisplatin have also reported [17, 18]. 
All of these studies provide rational for exploring SW 
as an anti-tumor agent. 
Apoptosis  is  a  tightly  controlled  physiological 
process  that  plays  a  critical  role  in  developmental 
modeling, homeostasis maintenance, immune reper-
toires, and clearance of infected or transformed cells 
[19]. Apoptosis can be triggered by various extracel-
lular and intracellular stimuli via either an extrinsic or 
intrinsic pathway in different cells [20]. The extrinsic 
pathway is initiated by cell surface receptors, while 
the intrinsic pathway is initiated by a mitochondria 
mediated  death  signaling  cascade  [20].  Compared 
with nontransformed cells, tumor cells are insensitive 
to some physiological stimuli that trigger physiologi-
cal cell death. For most of chemotherapy drugs, acti-
vation of apoptotic pathways to kill tumor cells is a 
predominant anti-tumor mechanism. Previous studies 
showed that SW inhibited the growth of human gas-
tric carcinoma SGC-7901 cells and rat C6 glioma cells 
via induction of apoptosis [9, 10], suggesting that SW 
might serve as an apoptotic inducer in tumor cells. Up 
to date, however, the molecular mechanisms have not 
yet been investigated. Therefore, we conducted this 
study to examine the effects of SW on human lung 
cancer A549 cells both in vivo and in vitro, and eluci-
date the possible mechanism involved in this process.  
Materials and methods 
Reagents 
SW was isolated from Oxytropis kansuensis Bunge 
(a kind of locoweed widely distributed in the west of 
China)  and  identified  by  interpretation  of  spectral 
data (MS, 1H NMR, 13C NMR, 2D NMR) as described 
previously [5]. Its purity was evaluated to be above 
99%. The alkaloid was dissolved in Ca2+- and Mg2+- 
free PBS (0.01 M, pH7.2), at 10 mM as stock solution, 
sterilized by ultrafiltration, and stored at –20 oC. 
RPMI-1640 medium and newborn bovine serum 
was obtained from GIBCO BRL (Grand Island, NY, 
US).  3-(4,5-Dimetylthiazol-2-yl)-2,5-diphenyltetrazo-
lium  bromide  (MTT),  4’,6-diamidino-2-phenylindole 
(DAPI), acridine orange (AO), ethidium bromide (EB), 
z-VAD-fmk,  z-DEVD-fmk,  z-LEHD-fmk  and 
z-IETD-fmk were all purchased from Sigma-Aldrich 
(St.  Louis,  MO,  US).  Mouse  monoclonal  antibodies 
against  caspase-8,  caspase-9,  caspase-3,  Bcl-2,  Bax, 
Fas,  Fas  ligand  (FasL),  cytochrome  c,  cytochrome  c 
oxidase  subunit  IV  (COX  IV),  poly  (ADP-ribose) 
polymerase (PARP) and β-actin were purchased from 
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, US). 
Horseradish  peroxidase-conjugated  secondary  anti-
body  was  purchased  from  Wuhan  Boster 
Bio-Engineering Co., Ltd. (Wuhan, China). All other 
chemicals  and  reagents  were  of  the  highest  quality 
and obtained from standard commercial sources. 
Cells culture and treatment 
Human  lung  cancer  cell  lines  A549,  Calu-3, 
SPC-A-1 and H1299 were obtained from the Cell Bank 
of  Type  Culture  Collection  of  Chinese  Academy  of 
Sciences  (Shanghai,  China)  and  cultured  in 
RPMI-1640  medium  (GIBCO  BRL)  supplemented 
with 10% new born bovine serum (GIBCO BRL), 100 
U/ml penicillin and 100 μg/ml streptomycin, at 37 oC 
in a 5% CO2 atmosphere incubator. Cells were treated 
with SW from a prepared stock solution in PBS, added 
to the culture medium to obtain final concentrations 
indicated as in each experiment. Equivalent volume of 
PBS was used as vehicle. 
Cell viability assay 
The  effects  of  SW  on  cell  viability  were  deter-
mined using the MTT assay. Briefly, 1×104 cells per 
well were plated in 96-well culture plates. After over-
night incubation, the cells were treated with different 
concentrations of SW (0, 1.5, 3, 6, 12 or 24 μM) for 24 h. 
The cells were treated with 50 μl of 5 mg/ml MTT and 
the resulting formazan crystals were dissolved in di-
methyl  sulfoxide  (DMSO).  The  absorbance  was 
measured  by  microplate  spectrophotometer  (Bio-tek 
Instruments, Inc., Winooski, US) at 570 nm. Results 
were expressed as percentage of the controls, which 
were arbitrarily assigned 100% viability. 
Apoptosis assessment by DAPI and AO/EB 
staining 
Cells  in  exponential  growth  were  seeded  into 
24-well culture plates. After overnight incubation, the 
cells  were  exposed  to  SW.  For  DAPI  staining,  the 
treated  cells  were  fixed  with  80%  ethanol  at  room 
temperature  for  30  min.  The  fixative  was  removed 
and the cells were washed with PBS for 3 times, and 
then  incubated  with  DAPI  (1  μg/ml)  for  45  min  at 
room temperature in the dark. For AO/EB staining, 
the cells without fixation were loaded with a 100 μl 
fresh-prepared AO/EB staining solution (100 μg/ml), 
then  immediately  observed  under  a  Nikon  fluores-
cence microscope (Nikon Inc., Japan) in less than 20 
min. Int. J. Biol. Sci. 2012, 8 
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Observation of ultrastructural morphology 
Transmission  electron  microscope:  After  SW 
treatment,  the  cells  were  fixed  with  4%  glutaralde-
hyde,  and  postfixed  with  1%  OsO4.  Then  samples 
were  dehydrated  in  graded  ethanol  solutions,  fol-
lowed by embedment and section. Ultrathin sections 
were stained with uranyl acetate and lead citrate, and 
then observed under a transmission electron micro-
scope (JEM-1230, Tokyo, Japan) at 60 KV. 
Scanning electron microscope: Cells were seeded 
on cover slips and treated with 12 μM of SW for 24 h, 
and then washed and fixed in 2.5% glutaraldehyde in 
PBS for 30 min followed by dehydration in a series of 
ethanol solutions of decreasing dilution. After critical 
point  dryer  and  ion  sputter  were  performed,  cells 
were observed under a scanning electron microscope 
(JSM-6360LV, Tokyo, Japan). 
DNA fragmentation assay 
After experimental treatment, both adherent and 
floating  cells  were  collected  and  washed  with  PBS. 
Pellets were then lysed with DNA lysis buffer (20 mM 
EDTA, 100 mM Tris, pH 8.0, 0.8% SDS) at room tem-
perature for 20 min. After centrifugation for 5 min at 
12  000  ×  g,  the  supernatants  were  collected  and 
treated with RNase A (final concentration, 500 μg/ml) 
for 30 min at 37 oC, followed by digestion with pro-
teinase K (final concentration 500 μg/ml) for 2 h at 55 
oC. The DNA was extracted using the phenol / chlo-
roform / isoamylol (25:24:1), precipitated with etha-
nol, dissolved in TE buffer (10 mM Tris, pH 8.0, 1 mM 
EDTA), and subjected to 2% agarose gel electropho-
resis for DNA fragmentation analysis. 
Flow cytometry analysis 
Annexin  V-FITC  /  PI  apoptosis  detection  kit 
(Becton-Dickinson, US) was used for apoptosis detec-
tion according to the manufacturer’s protocol. Cells 
were washed twice with PBS and resuspended in 100 
μl 1 × Annextin V binding buffer containing 5 μl of 
Annexin V-FITC and 5 μl of PI. After incubation in the 
dark for 10 min at room temperature, cells were di-
luted with 400 μl 1 × Annextin V binding buffer and 
analyzed by flow cytometry (Beckman Coulter, Inc. 
Fullerton, CA. US).  
Caspase activity assay 
Caspases activities were measured by colorimet-
ric  assay  kits  (BioVision,  Inc.,  Mountain  View,  CA, 
US)  according  to  the  manufacture’s  recommenda-
tions.  Briefly,  cells  were  pelleted  and  lysed  on  ice, 
protein concentration was measured using BCA Pro-
tein  Assay  Reagent  (Pierce,  Rockford,  IL,  US),  then 
200 μg of protein was incubated with each caspase 
substrate  at  37  oC  in  a  microplate  for  4  h.  Samples 
were read at 405 nm in microplate spectrophotometer 
(BioTek Instruments, Inc., Winooski, US). 
Western blot analysis 
The SW-treated cells were collected and washed 
with  ice-cold  PBS,  then  treated  with  ice-cold  RIPA 
lysis  buffer  (Beyotime  Inst.  Biotech,  Beijing,  China) 
with  1  mM  phenylmethyl  sulfonylfluoride  (PMSF). 
Cell lysates were centrifuged at 12 000 × g at 4 oC for 5 
min.  The  proteins  of  mitochondrial  and  cytosolic 
fraction were isolated using the Mitochondria / cy-
tosol  Fractionation  Kit  (BioVision,  Inc.,  Mountain 
View,  CA,  US)  according  to  the  manufacturer  in-
structions. The protein concentration was determined 
using the BCA Protein Assay Kit (Pierce, Rockford, IL, 
US).  Equivalent  amounts  of  proteins  samples  were 
uploaded and separated by 12% SDS-PAGE and then 
electrotransferred  to  polyvinylidene  difluouride 
(PVDF) membrane (Millipore Corp, Atlanta, GA, US). 
The membranes were blocked in 5% non-fat dry milk 
in PBS-T at room temperature for 1 h, and then incu-
bated with indicated primary antibodies over night at 
4 oC, followed by horseradish peroxidase-conjugated 
secondary antibodies at room temperature for 1 h. The 
signal was detected by enhanced cheniluminescence 
(ECL) reagents (Pierce, Rockford, IL, US). 
Real-time RT-PCR analysis 
Total  RNA  was  isolated  from  SW-treated  cells 
and  reverse  transcribed  with  MMLV  reverse  tran-
scriptase and oligodT primers. Quantitation of genes 
coding for Bcl-2 was performed using SYBR Premix 
Ex TaqTM II kit (Takara, Dalian, China) by Bio-Rad iQ 
5 Real Time PCR System. The β-actin gene was used 
as  an  endogenous  control.  The  primer  sequences 
were:  TTGAGGAAGTGAACATTTCGGTG  (for-
ward),  AGGTTCTGCGGACTTCGGTC  (reverse)  for 
Bcl-2;  AGTTGCGTTACACCCTTTCTTG  (forward), 
TCACCTTCACCGTTCCAGTTT (reverse) for β-actin. 
The  gene  expression  fold  changes  were  calculated 
using cycle time (Ct) values as described previously 
[21]. 
Antitumor activity in vivo 
Female  congenital  athymic  BALB/c  nude 
(nu/nu)  mice  were  purchased  from  Shanghai  Na-
tional  Center  for  Laboratory  Animals  (Shanghai, 
China) and maintained in pathogen-free conditions. 
Exponentially  growing  A549  cells  suspended  in  se-
rum-free medium were injected subcutaneously into 
the back of the 4-weeks old mice (1×106 cells in 100 μl). 
After  tumor  transplantation  for  1  week,  mice  were 
divided randomly into three groups (n = 6) and orally Int. J. Biol. Sci. 2012, 8 
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administrated PBS (control group), 1 mg/kg/d or 2.5 
mg/kg/d does of SW in PBS in a 0.2-ml volume, re-
spectively, for 15 consecutive days. These doses are 
chosen as safe and effective in mice model according 
to the previous report [8]. The length (a) and width (b) 
of tumor were regularly measured for 3-4 times every 
week by a caliper and the tumor volumes were then 
calculated according to the formula [(a × b2) / 2]. At 
the termination of the experiment, xenograft tumors 
were  excised  and  weighed  to  record  wet  tumor 
weight.  A  portion  of  the  tumors  from  control  and 
treated animals were fixed in 4% paraformaldehyde, 
embedded in paraffin, and cut into 6 μm sections for 
histologic  study,  and  that  the  rest  were  used  for 
preparation  of  tumor  lysate  used  in  further  experi-
ments.  The  animal  experiments  were  performed  in 
accordance with the ‘Guidelines for Animal Experi-
mentation’ of the Forth Military Medicine University. 
TUNEL assay  
Xenograft tumors were fixed in 4% paraformal-
dehyde, embedded in paraffin and cut into 6 μm sec-
tions.  Terminal  deoxynucleotidyl  transfer-
ase-mediated dUTP nick end labeling (TUNEL) assay 
was conducted to study DNA fragmentation using the 
in situ cell death detection kit (Beyotime Inst. Biotech, 
Beijing,  China)  according  to  the  manufacturer’s  in-
structions. After mounting the TUNEL positive cells, 
the  sections  were  observed  at  ×  400  magnification 
under a Nikon microscope (Nikon Inc., Japan). 
Immunohistochemistry analysis the expres-
sion of Bax and Bcl-2 
Fresh tumor tissue sections were incubated with 
primary  antibodies  against  Bax  (1:100)  and  Bcl-2 
(1:100) (Santa Cruz Biotechnology, US), biotinylated 
secondary antibody IgG, respectively, followed visu-
ally using SABC kit according to its protocol (Maixin 
Biological Technology Company, Fuzhou, China). The 
tissue  sections  were  viewed  at  ×  400  magnification 
under a Nikon microscope (Nikon Inc., Japan). 
Statistical analysis 
Data are expressed as the means ± SD. For each 
assay,  student’s  t-test  was  used  for  statistical  com-
parison. A probability of p < 0.05 was considered sig-
nificant. 
Results 
SW inhibits the growth of various human lung 
cancer cell lines 
Firstly, we investigated the effects of SW treat-
ment on the growth of various lung cancer cell lines, 
including  A549,  Calu-3,  H1299  and  SPC-A-1.  As 
shown in Fig. 1, SW inhibited the growth of these cell 
lines in a concentration-dependent manner. 3 μM of 
SW  significantly  reduced  the  cell  viabilities  of  all 
tested cell lines after 24 h exposure. 
 
 
Figure 1. The effects of SW treatment on different lung cancer 
cell lines. Cells were seeded in 96-well plates and treated with 
various concentrations of SW for 24 h. After the end of treatment, 
cell viabilities were determined by MTT assay. The values were 
calculated relative to the control group (0 μM). The results are 
mean ± SD and representative of three independent experiments. 
* p < 0.05; ** p < 0.01 versus the control group (0 μM of SW). 
 
SW treatment induces apoptosis in human 
lung cancer A549 cells  
To determine whether the observed decrease in 
cell  viability  was  associated  with  apoptosis,  we  ex-
amined the nuclear morphology using a Nikon fluo-
rescence  microscope.  A549  cells  were  treated  with 
different concentrations (0, 3, 6, 12 and 24 μM) of SW 
for 24 h (Fig. 2A, B), or 12 μM of SW for indicated 
times  (Fig.  2C,  D),  followed  by  DAPI  and  AO/EB 
staining. The control cells did not appear significant 
changes  in  cell  nuclei  and  cell  membrane  integrity, 
whereas SW-treated cells appeared different extent of 
chromatin  condensation,  nuclear  fragmentation  and 
destruction of cell membrane integrity after 24 h of 
incubation with different concentrations of SW, par-
ticularly  with  24  μM  of  SW  (Fig.  2A,  B).  Typical 
apoptotic nuclei were observed as early as 12 h in cells 
treated with 12 μM of SW (Fig. 2C, D). Characteristi-
cally morphological changes of apoptosis  were also 
observed  under  transmission  and  scanning  electron 
microscope in A549 cells treated with 12 μM of SW for 
24  h,  including  cell  shrinkage,  volume  reduction, 
chromatin condensation, cell blebbing and formation 
of membrane embedded apoptotic bodies (Fig. 2E, F). Int. J. Biol. Sci. 2012, 8 
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Figure 2. SW induces concentration- and time-dependent apoptosis in A549 cells. (A-D) Cells were treated with SW at different 
concentrations (0-4 μM) for 24 h (A, B) or treated with 12 μM of SW for different times (0-48 h) (C, D). Nuclear morphological changes 
in A549 cells were observed under fluorescent microscope after DAPI or AO/EB staining (400×). (E, F) Cells were treated with 12 μM of 
SW for 24 h. Ultrastructural morphology was visualized under transmition electron microscopy (E) and scanning electron microscopy (F). 
Arrows show chromatin condensation (E) and membrane embedded apoptotic bodies (F). (G) Induction of DNA fragmentation. DNA 
isolated from SW-treated cells was subjected to 2% agarose gel electrophoresis, followed by visualization of bands and photography. (H) 
Apoptosis rate of A549 cells. SW-treated cells were stained with Annexin V-FITC and PI for 10 min at room temperature, followed by 
FCM analysis. The Annexin V positive cells were regarded as apoptotic. The results are mean ± SD and representative of three inde-
pendent experiments. * p < 0.05, ** p < 0.01 versus the control group. 
 Int. J. Biol. Sci. 2012, 8 
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Besides changes in cell morphology, DNA frag-
mentation of SW-treated cells was also examined by 
observation  of  the  formation  of  DNA  ladder.  As 
shown in Fig. 2G, DNA ladder appeared to be more 
evident  with  the  increasing  of  SW  concentration, 
however,  no  DNA  fragments  were  observed  in  the 
control  groups  (Fig.  2G,  left  panel).  When  the  cells 
were treated with 12 μM of SW, DNA fragments were 
observed at 12 h, and more evident at 48 h (Fig. 2G, 
right panel). The SW-induced apoptosis was further 
determined by flow cytometry using Annexin V/PI 
dual staining. When A549 cells were treated with dif-
ferent concentrations (0-24 μM) for 24 h, the average 
percentage of apoptotic cells (Annexin V+) increased 
from 3.2% of the control to 71.5% (Fig. 2H, left panel). 
When the cells were treated with  12 μM of SW for 
indicated time (0-24 h), the rate of apoptotic cells sig-
nificantly increased over 12 h, and reached about 42.7% 
over 24 h of incubation (Fig. 2H, right panel). Taken 
together,  these  results  demonstrated  that  SW  treat-
ment induced A549 cells apoptosis in a concentration- 
and  time-dependent  manner.  In  addition, 
SW-induced  apoptosis  was  also  observed  in  Calu-3 
cells, H1299 cells and SPC-A-1 cells (Fig. 3A, B).  
Activation of caspase-9 and -3, but not caspa-
se-8, is involved in SW-induced apoptosis 
In the present study, we investigated the possi-
ble  mechanisms  of  SW-induced  apoptosis  in  A549 
cells. Since caspases are known to play a pivotal role 
in  mediating  various  apoptotic  signaling,  we  meas-
ured the activity of initiator caspases (caspase-8 and 
-9)  and  effector  caspase  (caspase-3)  in  SW  treated 
cells. As shown in Fig. 4A, exposure of A549 cells to 12 
μM of SW led to increased levels of activated caspa-
se-9  and  -3  and  caused  cleavage  of  PARP  in  a 
time-dependent manner during the treatment period. 
The  activated  forms  of  caspases-9  and  -3  were  ob-
served as early as 6 h. In contrast, the cleavage pro-
caspase-8  was  not  observed  in  this  study.  The 
SW-induced  caspases  activation  was  further  con-
firmed  by  measuring  the  enzymatic  activities  of 
caspases-8, -9, and -3 using the colorimetric assay kits. 
As shown in Fig. 4B, SW-treatment significantly in-
creased the activities of caspases-9 and -3 but had no 
effects on the activity of caspase-8 during the treated 
period. 
 
 
Figure 3. SW induces apoptosis in Calu-3, H1299 and SPC-A-1 cells. (A) Calu-3, H1299 and SPC-A-1 cells were treated with the 
indicated concentrations of SW for 48 h. DNA was extracted and analyzed on 2% agarose gel. (B) Calu-3, H1299 and SPC-A-1 cells were 
treated with the indicated concentrations of SW for 24 h, followed by Annexin V / PI staining and FCM analysis. The Annexin V positive 
cells were regarded as apoptotic. The results are mean ± SD and representative of three independent experiments. * p < 0.05, ** p < 0.01 
versus the control group (0 μM). Int. J. Biol. Sci. 2012, 8 
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Figure 4. SW-induced apoptosis is mediated by activation of caspase-9 and -3. (A) A549 cells were treated with 12 μM of SW for 
indicated time. Whole cell lysates were subjected to western blot analysis to detect total and activated caspase-8, -9, -3 and PARP. The 
data shown are representative of three independent experiments. (B) Caspase activities in cells treated with SW. Cells were incubated 
with 12 μM of SW for indicated times and the enzymatic activities of caspases-8, -9, and -3 were measured using the colorimetric assay kits. 
The results are mean ± SD and representative of three independent experiments. * p < 0.05, ** p < 0.01 versus the control group (0 h). 
(C) Effect of caspase inhibitors on SW-induced cleavage of PARP. Cells were incubated with 20 μM of caspase inhibitors, z-VAD-fmk, 
z-DEVD-fmk, z-IETD-fmk or z-LEHD-fmk for 1 h and then co-incubated with 12 μM of SW for 24 h. Expression level of PARP was 
analyzed by Western blot. The data shown are representative of three independent experiments. (D) Effects of caspase inhibitors on 
SW-induced apoptosis. A549 Cells were treated as in C. Rate of apoptosis was evaluated by FCM analysis. Data are mean ± SD and 
representative of three independent experiments. ** p < 0.01 versus SW alone without inhibitor. 
 
 
 
To further determine the involvement of caspa-
ses in SW-induced apoptosis, four caspase inhibitors, 
z-VAD-fmk  (pan  caspase  inhibitor),  z-IETD-fmk 
(caspase-8 specific inhibitor), z-LEHD-fmk (caspase-9 
specific  inhibitor)  and  z-DEVD-fmk  (caspase-3  spe-
cific inhibitor) were used to block intracellular prote-
ase, and then the SW-induced cleavage of PARP and 
apoptotic rate  was detected using western blot and 
flow cytometry assay. Z-VAD-fmk, z-LEHD-fmk, or 
z-DEVD-fmk  inhibited  SW-induced  cleavage  of 
PARP, whereas z-IETD-fmk (caspase-8 inhibitor) did 
not (Fig. 4C). In consistent with this result, the apop-
tosis of SW-treated cells was prevented almost wholly 
by  z-VAD-fmk,  in  part  by  z-LEHD-fmk  and 
z-DEVD-fmk,  but  not  by  z-IETD-fmk  after  24  h  of 
co-treatment  (Fig.  4D).  These  results  suggested  that 
the SW-induced apoptosis was dependent on the ac-
tivation of caspases and mainly executed through the 
activation of caspase-9 and -3. 
SW treatment activates the mitochondrial 
apoptotic pathway involving the regulation of 
Bcl-2 family members 
Apoptosis is usually induced through two dis-
tinct signaling pathways: the death receptor pathway 
and the mitochondrial pathway. The death receptor 
pathway is usually triggered by ligation of death re-
ceptors such as Fas or tumor necrosis factor receptor, 
which recruits fas associated protein with death do-
main  (FADD)  and  procaspase-8  to  form  a 
death-inducing signaling complex, leading to caspa-
se-8  proteolytic  activation.  Activated  caspase-8  can 
not only directly activates downstream caspase-3, but 
also cleave Bid to truncated Bid (tBid), which in turn 
activates the mitochondrial pathway [22]. Consistent 
with the results of caspase-8, SW treatment also did 
not  affect  the  levels  of  Fas  and  FasL,  or  promote 
cleavage  of  Bid  (Fig.  5A,  B).  These  results  further 
suggested  that  SW  treatment  might  not  activate 
Fas-mediated death receptor pathway in A549 cells. Int. J. Biol. Sci. 2012, 8 
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The mitochondrial pathway usually involves the 
release of mitochondrial cytochrome c to the cytosol. 
Once released, cytochrome c combines with apoptotic 
protease activating factor 1 (Apaf-1) and procaspase-9 
to form the apoptosome in the presence of ATP, re-
sulting in the activation of caspse-9 and caspase-3 [23]. 
The  Bcl-2  family  members  are  known  to  play  im-
portant roles in controlling the release of cytochrome c 
from  mitochondria.  Upon  apoptotic  signals, 
pro-apoptotic Bcl-2 members, such as Bax, Bak or Bid, 
are activated; in contrast anti-apoptotic Bcl-2 member 
Bcl-2 and Bcl-XL can prevent this occurrence [24]. The 
imbalance  of  expression  of  pro-  and  anti-apoptotic 
proteins is associated with the ultimate fate of cells 
[25]. To assess whether mitochondrial pathway is in-
volved  in  SW-induced  apoptosis,  we  evaluated  the 
expression levels of Bax and Bcl-2 by western blot. As 
shown in Fig. 5B, exposure of A549 cells to 12 μM of 
SW for different times (0-24 h), Bax protein levels in-
creased,  whereas  Bcl-2  protein  levels  decreased 
gradually  with  time.  Thus,  SW  treatment  increased 
the ratio of Bax/Bcl-2, which is in favor of the occur-
rence of apoptosis. The reduction of Bcl-2 in mRNA 
levels might contribute to the shift in the Bax/Bcl-2 
ratio (Fig. 5C). Next, we detected the location of Bax 
and cytochrome c in the proteins extracts from both 
mitochondrial  and  cytosolic  fractions  of  SW-treated 
cells.  A  translocation  of  Bax  from  cytosol  to  mito-
chondria was observed as early as 6 h post-treatment 
(Fig. 5D). Consistent with this, a time-dependent de-
crease in mitochondrial cytochrome c and a concomi-
tant  increase  in  the  cytosolic  fraction  were  also  ob-
served  (Fig.  5D).  These  results  suggested  that  SW 
treatment-induced apoptosis was mainly through the 
activation of mitochondrial pathway. 
 
 
Figure 5. SW-induced A549 cell apoptosis is mediated by the activation of mitochondrial pathway. A549 cells were incubated with 12 μM 
of SW for indicated time. The cell lysates were subjected to Western blot analysis, while total RNA was extracted and used for real-time 
RT-PCR assay. (A) SW treatment did not affect the levels of Fas or FasL. (B) SW treatment did not promote the cleavage of Bid, but 
increased the ratio of Bax/Bcl-2. The values were calculated from the bands corresponding to Bax and Bcl-2 that normalized to β-actin. (C) 
SW treatment decreased the expression of Bcl-2 at mRNA levels. The results are mean ± SD and representative of three independent 
experiments. * p < 0.05 versus the control group (0 h). (D) SW treatment promoted Bax translocation and cytochrome c release. Cells 
were treated with 12 μM of SW for the indicated times. The cytosolic and mitochondrial fraction proteins were collected and then 
detected by western blot. COX IV and β-actin were used as internal controls for the mitochondrial fractions and the cytosolic fraction, 
respectively. All the data shown are representative of three independent experiments. Int. J. Biol. Sci. 2012, 8 
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SW intake inhibits growth of A549 xenografts 
in athymic nude mice 
SW  has  been  shown  to  be  effectively  induced 
apoptosis in A549 cells; therefore, we further extend-
ed our study to determine whether these events occur 
in vivo using a xenograft mouse model. Athymic nude 
mice xenografted with A549 cells were divided into 
control  group  and  SW-treated  groups  wherein  SW 
was administered at doses of 1 or 2.5 mg/kg/day for 
15 days. Contrast with control group, tumor volume 
was inhibited by 27% and 41% (p < 0.05) and the wet 
weight of tumor was decreased by 24% and 36% (p < 
0.05) in 1 and 2.5 mg/kg/day SW-treated group, re-
spectively, at the termination of the experiment (Fig. 
6A, B). SW administration did not seem to induce any 
adverse effects as judged by monitoring body weight 
and livers and kidneys (data not shown). No patho-
logical changes were observed in the lung histology of 
mice from the SW-treated group (Fig. 6C, left panel). 
Furthermore, we evaluated the effects of SW intake on 
the  induction  of  apoptosis  and  apoptosis-associated 
molecules in tumor xenografts. TUNEL assay showed 
evident in situ apoptosis in A549 tumor sections at 1 
and 2.5 mg/kg/day of SW-treated groups, but not in 
the  sections  of  control  group  (Fig.  6C  mid  panel). 
Immunohistochemistry  and  western  blot  analysis 
showed  that  SW  administration  resulted  in  an  in-
crease in the protein levels of Bax, decrease in Bcl-2 
and  simultaneous activation of caspase-3, the redis-
tribution of Bax and cytochrome c compared to mice 
receiving vehicle treatment (Fig. 6C right panels, D), 
which is consistent with our findings in cell culture. 
These data suggested that SW administration inhib-
ited A549 xenograft tumors growth via induction of 
tumor cell apoptosis. 
Discussion 
Previous studies have shown that SW inhibits a 
number of human tumors including colorectal carci-
noma, melanoma, hepatoma, breast carcinoma, pate 
malignant tumor and gastric carcinoma as well as in 
murine lymphoma tumor cells, melanoma cell, S180 
ascites tumor and rat glioma cells in vitro or in vivo 
[8-10, 12, 26]. In the present study, we evaluated the 
effects of SW on several human lung cancer cell lines 
in vitro and  A549 in vivo.  The  results  demonstrated 
that SW reduced the survival of the cancer cells and 
inhibited  the  growth  of  A549  xenograft  tumors 
through induction of apoptosis. In addition, we pro-
vided  evidence that SW  induced apoptosis  in A549 
cells  through  the  cytochrome  c-mediated,  caspa-
se-dependent pathway. 
Many previous reports have indicated that a lot 
of anticancer drugs or cancer chemopreventive agents 
act through the induction of apoptosis to prevent tu-
mor  promotion  and  progression  [27,  28].  Sun  et al. 
reported that the growth inhibition effect of SW on 
SGC-7901 cells and C6 glioma cells might be through 
induction of apoptosis [9, 10]. In the current in vitro 
study,  we  observed  that  SW  inhibited  cell  growth 
through  induction  of  apoptosis  in  A549  cells  in  a 
concentration-  and  time-dependent  manner,  as  evi-
dent  by  the  phosphatidylserine  externalization,  ap-
pearance  of  membrane  enclosed  apoptotic  bodies, 
DNA laddering fragment, as well as caspases activa-
tion  and  PARP  cleavage.  SW  has  been  reported  to 
inhibit solid tumors through  direct and indirect ac-
tions on the tumor cells in vivo, and the two possible 
mechanisms have been elucidated in previous studies. 
Firstly, it inhibits tumor cell metastasis and invasion 
by modifying the expression of glycoprotein on the 
tumor  cell  surface  as  an  oligosaccharide-processing 
inhibitor. Tumor cells cultured in the presence of SW 
show loss of invasiveness into extracellular matrix, as 
well as loss of organ colonization potential when in-
jected i.v. into mice [29]. Secondly, SW acts as an an-
ticancer  immunomodulatory  agent.  SW  alleviates 
tumor-induced  immune  suppression  and  stimulates 
NK cell, macrophage, and LAK cell-mediated tumor-
icide activity [16, 26, 30, 31]. In this study, significant 
apoptosis  were  observed  by  TUNEL  assay  in  the 
xenograft tumors in mice orally received SW at doses 
of 1 and 2.5 mg/kg/day. Our results demonstrate that 
SW also serves as an apoptosis inducer both in vitro 
and in vivo. 
Next, we investigated the possible mechanisms 
of SW-induced apoptosis in A549 cells. Caspases have 
been known to play a pivotal role in the execution of 
apoptosis.  The  two  major  caspases  activation  path-
ways,  i.e.,  death  receptor  and  mitochondrial  path-
ways, have been well described [20]. In death receptor 
pathway,  apoptosis  occurs  upon  the  stimulation  of 
death receptors in the cell surface to activate caspa-
se-8. The mitochondrial pathway is dependent on the 
release of cytochrome c from mitochondria to the cy-
tosol, resulting in the activation of caspase-9. Caspa-
se-8  and  caspase-9  will  then  proteolytically  activate 
downstream caspases, in particular caspases-3, which 
is essential for the morphological change and DNA 
fragmentation  associated  with  apoptosis.  There  are 
also evidences that apoptosis can be induced through 
caspase-independent mechanism [32].  Int. J. Biol. Sci. 2012, 8 
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Figure 6. SW administration inhibits A549 tumor growth in athymic nude mice via induction of apoptosis. Approximately 1×106 A549 
cells were injected into back of mouse, and SW was provided to mice 1 week after cell inoculation. Mice were divided into three groups: 
Group I received 0.2 ml PBS only as control; Group II received 1 mg/kg SW in 0.2 ml PBS; Group III received 2.5 mg/kg SW in 0.2 ml PBS 
daily for 15 days. (A) Tumor volumes (mm3) were measured regularly in two dimensions throughout the study. Data are represented as 
the mean of 6 tumors from each group. * p < 0.05 versus the control group. (B) Wet weight of tumors were measured in the end of this 
experiment. Data are represented as the mean of 6 tumors from each group. * p < 0.05 versus the control group. (C) The host’s lung 
tissues were examined by H&E staining. Tumor tissues were examined by H&E staining, TUNEL assay and immunohistochemistry staining 
with anti-Bax and Bcl-2 primary antibodies. (D) Western blot analysis of cytochrome c, Bax, Bcl-2, and caspase-3 in tumor tissue lysates 
after intake of indicated doses of SW. The data are representative of three independent experiments. 
 
In  this  study,  we  observed  that  the  process  of 
SW-induced  apoptosis  involved  the  activation  of 
caspase-9  and  -3,  and  that  the  treatment  with 
pan-caspase inhibitor or specific inhibitors of caspa-
se-9  and  -3  significantly  prevented  the  SW-induced 
cell apoptotic effects. Thus, our results  demonstrate 
that the SW-induced apoptosis is dependent on the 
activation of caspases, especially capase-9 and -3. As a 
low molecular weight and water soluble alkaloid, SW 
can quickly enter the cytoplasma rather than persis-
tently stay on the cell membrane, which implies the 
possibility  that  mitochondria-mediated  caspase-9/-3 Int. J. Biol. Sci. 2012, 8 
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activation pathway should be responsible for the SW 
induced apoptosis. Coincidentally, SW treatment did 
not activate capase-8 or its upstream molecules such 
as Fas and FasL. Just like some compounds such as 
sulforaphane and γ-tocotrienol, which induce apop-
tosis by directly impairing the mitochondrial integrity 
in certain cell types [33, 34], SW failed to activate the 
death  receptor-mediated  caspase-8  pathway  in  this 
study. 
Mitochondria  play  an  essential  role  in  death 
signal transduction and amplification of the apoptotic 
response.  An  important  role  of  mitochondria  in 
apoptotic signaling is the translocation of cytochrome 
c  from  the  mitochondrial  intermembrane  compart-
ment  into  the  cytosol.  Once  released,  cytochrome  c 
together with Apaf-1 activates caspase-9, and the lat-
ter then activates caspase-3 [35]. The release of cyto-
chrome  c  and  cytochrome  c-mediated  apoptosis  is 
controlled prominently by the members of Bcl-2 fam-
ily, of which Bax and Bcl-2 have been identified as 
major regulators. In response to a variety of stimuli 
including  anticancer  drugs,  Bax  translocates  to  the 
mitochondria and inserts into the outer mitochondrial 
membrane, where allows the release of cytochrome c. 
In contrast, Bcl-2 blocks cytochrome c efflux by bind-
ing to the outer mitochondrial membrane and form-
ing a heterodimer with Bax resulting in neutralization 
of its proapoptotic effects [36]. Therefore, the balance 
between the levels of Bcl-2 and Bax is critical in de-
termining the fate of cells, survival or death. Results 
obtained  in  the  present  study  demonstrated  that 
SW-treatment increased the ratio of Bax/Bcl-2, pro-
moted  the  redistribution  of  Bax  and  cytochrome  c 
both in vitro and in vivo, suggesting that the increase of 
the  ratio  of  Bax/Bcl-2  might  be  the  key  factor  of 
SW-induced apoptosis. These results provide further 
insight  into  SW-induced  apoptosis  and  deepen  the 
mechanisms  of  anticancer  activity  of  SW,  and  can 
provide a rational for developing SW to be a promis-
ing chemotherapeutic agent in future. 
In summary, our results demonstrate that SW is 
an  inducer  of  apoptosis  in  A549  cells.  The 
SW-induced  apoptosis  is  dependent  on  the  mito-
chondria-mediated  caspase  activation  and  involve-
ment of the regulation of Bcl-2 and Bax (Fig. 7). These 
data provided a clue to understand the mechanisms of 
SW-induced apoptosis. It is probable that we are far 
from unveiling the complete mechanisms underlying 
SW induction of the growth inhibition and apoptosis 
of tumor cells, and that other signaling components 
such as p53 might be involved. Work ongoing in our 
laboratory is addressing these issues. 
 
Figure  7.  Proposed  model  of  molecular  mechanism  of 
SW-induced apoptosis in A549 cells. SW treatment up-regulates 
Bax, down-regulates Bcl-2 expression, promotes Bax transloca-
tion to mitochondria, activates mitochondria-mediated apoptotic 
pathway, which in turn causes the release of cytochrome c, the 
activation of caspase-9 and caspase-3, and the cleavage of PARP 
and fragmentation of internucleosomal DNA, resulting in A549 
cell apoptosis. 
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